Postconditioning in reperfusion injury: a status report
- PMID: 20532970
- DOI: 10.1007/s10557-010-6240-1
Postconditioning in reperfusion injury: a status report
Abstract
Early reperfusion after an organ ischemia is essential to salvage tissue from eventual death. However, abundant evidence suggests that reperfusion also elicits pathophysiological changes responsible for additional tissue injury after restoration of blood flow. Postconditioning (Postcon) defined as rapid sequential intermittent interruption of blood flow applied during early moments of reperfusion has successfully shown to attenuate organ injury, including the heart, spinal cord, brain, kidney, liver, muscle, lung and intestines in the experimental setting. Clinical trials have also revealed the beneficial effect of Postcon on myocardial infarction in patients undergoing percutaneous coronary intervention or coronary artery bypass graft surgery. Although there are some controversial issues regarding the efficacy of protection with Postcon in different animal models with comorbities, most preclinical studies have shown that Postcon is a potent intervention to reduce organ necrosis and apoptosis. Remote or pharmacological Postcon has emerged as alternatives in amelioration of cardiac reperfusion injury. This article will primarily discuss the existing literature regarding protection of Postcon on the heart, but there is a potential for future research into other organ systems to identify beneficial effects of Postcon on tissue reperfusion injury, particularly in patients undergoing surgical revascularization.
Similar articles
-
Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans.Clin Sci (Lond). 2011 Mar;120(6):251-61. doi: 10.1042/CS20100369. Clin Sci (Lond). 2011. PMID: 20919993 Clinical Trial.
-
Postconditioning attenuates early ventricular arrhythmias in patients with high-risk ST-segment elevation myocardial infarction.J Cardiol. 2015 Jun;65(6):459-65. doi: 10.1016/j.jjcc.2015.02.010. Epub 2015 Mar 29. J Cardiol. 2015. PMID: 25828740 Clinical Trial.
-
Myocardial protection with postconditioning is not enhanced by ischemic preconditioning.Ann Thorac Surg. 2004 Sep;78(3):961-9; discussion 969. doi: 10.1016/j.athoracsur.2004.03.033. Ann Thorac Surg. 2004. PMID: 15337028
-
Oxidative and inflammatory biomarkers of ischemia and reperfusion injuries.Dan Med J. 2015 Apr;62(4):B5054. Dan Med J. 2015. PMID: 25872540 Review.
-
The science and clinical translation of remote postconditioning.J Cardiovasc Med (Hagerstown). 2013 Mar;14(3):206-13. doi: 10.2459/JCM.0b013e32835cecc6. J Cardiovasc Med (Hagerstown). 2013. PMID: 23412366 Review.
Cited by
-
Ischemic postconditioning decreases matrix metalloproteinase-2 expression during ischemia-reperfusion of myocardium in a rabbit model: A preliminary report.Exp Clin Cardiol. 2013 Spring;18(2):e99-e101. Exp Clin Cardiol. 2013. PMID: 23940456 Free PMC article.
-
Role of Mesenchymal Stem/Stromal Cells in Modulating Ischemia/Reperfusion Injury: Current State of the Art and Future Perspectives.Biomedicines. 2023 Feb 23;11(3):689. doi: 10.3390/biomedicines11030689. Biomedicines. 2023. PMID: 36979668 Free PMC article. Review.
-
Postconditioning in major vascular surgery: prevention of renal failure.J Transl Med. 2015 Jan 27;13:21. doi: 10.1186/s12967-014-0379-7. J Transl Med. 2015. PMID: 25622967 Free PMC article.
-
Inhibition of autophagy by CRMP2-derived peptide ST2-104 (R9-CBD3) via a CaMKKβ/AMPK/mTOR pathway contributes to ischemic postconditioning-induced neuroprotection against cerebral ischemia-reperfusion injury.Mol Brain. 2021 Aug 6;14(1):123. doi: 10.1186/s13041-021-00836-0. Mol Brain. 2021. PMID: 34362425 Free PMC article.
-
Effect of postconditioning on dynamic expression of tenascin-C and left ventricular remodeling after myocardial ischemia and reperfusion.EJNMMI Res. 2015 Apr 2;5:21. doi: 10.1186/s13550-015-0100-8. eCollection 2015. EJNMMI Res. 2015. PMID: 25883880 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources